Skip to Main Content

Paper Details

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Haematologica
5
2023
-MYC, -MYC rearrangement, /, ABL, B-cell, B-cell precursor, B-cell precursor acute lymphoblastic leukaemia, BCL2, BCL6, BCL6-rearrangements, BCP, BCP-ALL, BCR, Burkitt leukaemia/lymphoma, Burkitt lymphoma/, Children, IG, IG-MYC, IG-MYC-r, KMT2A, KMT2A-rearrangement, KRAS, MYC, iAMP21, immature B-cell, immature B-cell precursor, immunoglobulin, leukaemia, patient
Author NameAffiliation
Yunfeng DaiColleges of Medicine, University of Florida
Gudrun G??hringHannover Medical School
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania
Mignon L LohBenioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California san francisco
Anthony V MoormanWolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University
  • 1 - 6

Datasets